Home Cart 0 Sign in  
X

[ CAS No. 501-52-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 501-52-0
Chemical Structure| 501-52-0
Chemical Structure| 501-52-0
Structure of 501-52-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 501-52-0 ]

Related Doc. of [ 501-52-0 ]

Alternatived Products of [ 501-52-0 ]

Product Details of [ 501-52-0 ]

CAS No. :501-52-0 MDL No. :MFCD00002771
Formula : C9H10O2 Boiling Point : -
Linear Structure Formula :- InChI Key :XMIIGOLPHOKFCH-UHFFFAOYSA-N
M.W : 150.17 Pubchem ID :107
Synonyms :
3-Phenylpropionic acid;3-Phenylpropanoic acid;NSC9272;NSC 9272 NSC-9272;Benzylacetic acid;3-Phenyl-n-propionic acid
Chemical Name :3-Phenylpropanoic acid

Calculated chemistry of [ 501-52-0 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 42.79
TPSA : 37.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.91 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.5
Log Po/w (XLOGP3) : 1.84
Log Po/w (WLOGP) : 1.7
Log Po/w (MLOGP) : 1.98
Log Po/w (SILICOS-IT) : 1.88
Consensus Log Po/w : 1.78

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.14
Solubility : 1.1 mg/ml ; 0.00731 mol/l
Class : Soluble
Log S (Ali) : -2.24
Solubility : 0.857 mg/ml ; 0.0057 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.56
Solubility : 0.413 mg/ml ; 0.00275 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 501-52-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 501-52-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 501-52-0 ]
  • Downstream synthetic route of [ 501-52-0 ]

[ 501-52-0 ] Synthesis Path-Upstream   1~28

  • 1
  • [ 91-64-5 ]
  • [ 4430-31-3 ]
  • [ 701-97-3 ]
  • [ 63714-95-4 ]
  • [ 501-52-0 ]
Reference: [1] Chinese Journal of Catalysis, 2015, vol. 36, # 7, p. 957 - 960
  • 2
  • [ 91-64-5 ]
  • [ 4430-31-3 ]
  • [ 701-97-3 ]
  • [ 20349-89-7 ]
  • [ 63714-95-4 ]
  • [ 119-84-6 ]
  • [ 501-52-0 ]
Reference: [1] Chinese Journal of Catalysis, 2015, vol. 36, # 7, p. 957 - 960
  • 3
  • [ 501-52-0 ]
  • [ 14548-51-7 ]
Reference: [1] Chemische Berichte, 1880, vol. 13, p. 1680
  • 4
  • [ 501-52-0 ]
  • [ 645-45-4 ]
YieldReaction ConditionsOperation in experiment
100% With oxalyl dichloride In dichloromethane at 20℃; 3-Phenylpropanoyl chloride (74). A 200 mL flask fitted with a stir-bar and septum with an Ar inlet was charged with hydrocinnamic acid (5.00 g, 33.3 mmol), DMF (0.1 mL), and CH2CI2 (30 mL). To the resultant solution was added (COCI)2 (2M in CH2CI2, 20.0 mL, 40.0 mmol) over 30 min. The mixture stirred overnight at rt, and then was concentrated in vacuo to give 5.9 g of 74 as a yellow oil (100percent). HPLC analysis (15:10:75 H2O:A1 :MeOH) showed a purity of 99percent with a retention time of 5.3 min.
100% With oxalyl dichloride In dichloromethane for 24 h; Inert atmosphere To a stirred solution of 3-phenylpropanoic acid (3.0 g, 20 mmol, 1 eq.) in anhydrous CH2Cl2 (165 mL) under nitrogen was added oxalyl chloride (16.5 mL 190 mmol, 10 eq.) rapidly via syringe. The reaction mixture was stirred for 24 h, after which the solvent and unreacted oxalyl chloride were Removed by distillation under reduced pressure. The resulting yellow liquid was concentrated via azeotrope with benzene (3 x 50 mL) in vacuo and dried under a vacuum to yield 37 (3.4 g, ~100percent) as a yellow liquid, which was used directly in the next step.
95% With thionyl chloride In benzene for 4 h; Reflux Dihydrocinnamic acid (10b) (3.0g, 0.02mol) was dissolved in dry benzene (5mL, 0.06mol) at room temperature then SOCl2 (10mL, 0.14mol) was added in a dropwise manner. The reaction mixture was allowed to heat at reflux for 4h. The solvent was evaporated under reduced pressure to give (3.4g, 95percent) of 11b as yellow oil. The crude product was used in the next step without further purification or characterization.
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 10, p. 2899 - 2903
[2] Patent: WO2013/101911, 2013, A2, . Location in patent: Page/Page column 57
[3] Arkivoc, 2018, vol. 2018, # 5, p. 334 - 347
[4] Advanced Synthesis and Catalysis, 2015, vol. 357, # 18, p. 3825 - 3830
[5] Journal of the American Chemical Society, 1980, vol. 102, # 20, p. 6311 - 6314
[6] Tetrahedron Letters, 1995, vol. 36, # 19, p. 3397 - 3400
[7] Tetrahedron, 2010, vol. 66, # 29, p. 5349 - 5356
[8] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 13, p. 2912 - 2919
[9] Organic and Biomolecular Chemistry, 2014, vol. 12, # 48, p. 9760 - 9763
[10] Journal of the Chemical Society - Perkin Transactions 1, 1998, # 24, p. 4077 - 4091
[11] Bioorganic and Medicinal Chemistry Letters, 1997, vol. 7, # 13, p. 1689 - 1694
[12] Journal of Medicinal Chemistry, 2001, vol. 44, # 10, p. 1491 - 1508
[13] Justus Liebigs Annalen der Chemie, 1902, vol. 323, p. 255
[14] Recueil des Travaux Chimiques des Pays-Bas, 1897, vol. 16, p. 35
[15] Journal fuer Praktische Chemie (Leipzig), 1905, vol. <2> 71, p. 330
[16] Justus Liebigs Annalen der Chemie, 1909, vol. 369, p. 319
[17] Journal fuer Praktische Chemie (Leipzig), 1905, vol. <2> 71, p. 330
[18] Journal of the American Chemical Society, 1980, vol. 102, # 11, p. 3917 - 3922
[19] Journal of the American Chemical Society, 1987, vol. 109, # 26, p. 8056 - 8066
[20] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 22, p. 4973 - 4978
[21] Journal of the American Chemical Society, 1974, vol. 96, p. 1518 - 1522
[22] Bulletin de la Societe Chimique de France, 1970, # 3, p. 907 - 912
[23] Journal of Organic Chemistry, 1973, vol. 38, # 8, p. 1439 - 1444
[24] Journal of Organometallic Chemistry, 1968, vol. 13, p. 45 - 51
[25] Canadian Journal of Chemistry, 1991, vol. 69, # 12, p. 2053 - 2058
[26] Recueil des Travaux Chimiques des Pays-Bas, 1993, vol. 112, # 2, p. 143 - 150
[27] Monatshefte fuer Chemie, 1990, vol. 121, # 4, p. 267 - 274
[28] Journal of Heterocyclic Chemistry, 1980, vol. 17, # 5, p. 1081 - 1085
[29] Bulletin de la Societe Chimique de France, 1990, # 6, p. 824 - 829
[30] Tetrahedron, 1987, vol. 43, # 16, p. 3689 - 3694
[31] Tetrahedron, 1988, vol. 44, # 12, p. 3501 - 3512
[32] Journal of the American Chemical Society, 1980, vol. 102, # 17, p. 5530 - 5538
[33] Journal of Organic Chemistry, 1984, vol. 49, # 1, p. 207 - 209
[34] Canadian Journal of Chemistry, 1980, vol. 58, p. 458 - 462
[35] Steroids, 1983, vol. 41, # 3, p. 309 - 320
[36] European Journal of Medicinal Chemistry, 1987, vol. 22, p. 283 - 292
[37] Synthetic Communications, 1982, vol. 12, # 14, p. 1139 - 1146
[38] Journal of the American Chemical Society, 1984, vol. 106, # 11, p. 3344 - 3353
[39] Journal of Medicinal Chemistry, 1986, vol. 29, # 12, p. 2465 - 2472
[40] Journal of Medicinal Chemistry, 1984, vol. 27, # 3, p. 325 - 341
[41] Journal of Heterocyclic Chemistry, 1992, vol. 29, # 2, p. 335 - 341
[42] Tetrahedron, 1991, vol. 47, # 34, p. 7091 - 7108
[43] Recueil: Journal of the Royal Netherlands Chemical Society, 1981, vol. 100, # 1, p. 21 - 24
[44] Australian Journal of Chemistry, 1993, vol. 46, # 12, p. 1845 - 1860
[45] Tetrahedron, 1994, vol. 50, # 25, p. 7343 - 7366
[46] Chemical Communications, 1996, # 22, p. 2595 - 2596
[47] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1996, vol. 35, # 6, p. 615 - 616
[48] Journal of the Chemical Society - Perkin Transactions 1, 1997, # 8, p. 1147 - 1156
[49] Revue Roumaine de Chimie, 1992, vol. 37, # 2, p. 289 - 298
[50] Journal of Medicinal Chemistry, 1999, vol. 42, # 21, p. 4446 - 4455
[51] Bioorganic and Medicinal Chemistry, 2001, vol. 9, # 3, p. 785 - 792
[52] Phytochemistry, 2002, vol. 59, # 1, p. 9 - 21
[53] Farmaco (Societa chimica italiana : 1989), 2002, vol. 57, # 3, p. 175 - 181
[54] Journal of Organometalic Chemistry, 2002, vol. 643-644, p. 404 - 408
[55] Journal of Medicinal Chemistry, 2003, vol. 46, # 13, p. 2589 - 2598
[56] Synthesis, 2003, # 15, p. 2415 - 2426
[57] Journal of Medicinal Chemistry, 2004, vol. 47, # 5, p. 1098 - 1109
[58] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 5, p. 1239 - 1242
[59] Journal of Medicinal Chemistry, 2005, vol. 48, # 6, p. 1849 - 1856
[60] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 13, p. 3257 - 3262
[61] Synthesis, 2005, # 15, p. 2521 - 2526
[62] Bioorganic and Medicinal Chemistry, 2006, vol. 14, # 7, p. 2209 - 2224
[63] Journal of Physical Organic Chemistry, 2006, vol. 19, # 11, p. 737 - 743
[64] Journal of Medicinal Chemistry, 2001, vol. 44, # 25, p. 4468 - 4474
[65] Journal of Organic Chemistry, 2000, vol. 65, # 13, p. 4179 - 4184
[66] Journal of the American Chemical Society, 2002, vol. 124, # 10, p. 2078 - 2079
[67] Journal of Organic Chemistry, 2000, vol. 65, # 5, p. 1442 - 1447
[68] Organic Letters, 2000, vol. 2, # 4, p. 539 - 541
[69] Russian Journal of Applied Chemistry, 2006, vol. 79, # 6, p. 1035 - 1037
[70] Organic and Biomolecular Chemistry, 2006, vol. 4, # 14, p. 2716 - 2723
[71] Tetrahedron, 1988, vol. 44, # 12, p. 3501 - 3512
[72] Patent: WO2006/84869, 2006, A1, . Location in patent: Page/Page column 80
[73] Patent: WO2007/149907, 2007, A2, . Location in patent: Page/Page column 52-53
[74] Patent: US2008/19930, 2008, A1, . Location in patent: Page/Page column 11
[75] Patent: US2008/19930, 2008, A1, . Location in patent: Page/Page column 12
[76] Patent: WO2008/64979, 2008, A2, . Location in patent: Page/Page column 50-51
[77] Patent: US2008/188533, 2008, A1, . Location in patent: Page/Page column 43
[78] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 10, p. 5514 - 5528
[79] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 17, p. 8054 - 8062
[80] Patent: US2004/9991, 2004, A1, . Location in patent: Page/Page column 50
[81] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 23, p. 9984 - 9990
[82] Australian Journal of Chemistry, 2008, vol. 61, # 11, p. 881 - 887
[83] Patent: EP2042494, 2009, A1, . Location in patent: Page/Page column 19
[84] Chemistry - A European Journal, 2008, vol. 14, # 30, p. 9240 - 9254
[85] Patent: US2009/298832, 2009, A1, . Location in patent: Page/Page column 13
[86] Patent: US2009/306214, 2009, A1, . Location in patent: Page/Page column 7
[87] Patent: WO2004/31129, 2004, A2, . Location in patent: Example 2
[88] Patent: EP1598353, 2005, A1, . Location in patent: Page/Page column 22
[89] Organic and Biomolecular Chemistry, 2009, vol. 7, # 17, p. 3561 - 3571
[90] Molecules, 2009, vol. 14, # 9, p. 3313 - 3338
[91] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 22, p. 7690 - 7697
[92] Patent: US2010/145060, 2010, A1, . Location in patent: Page/Page column 7-8
[93] Synthesis, 2010, # 11, p. 1845 - 1859
[94] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 17, p. 5123 - 5125
[95] Patent: WO2006/26430, 2006, A2, . Location in patent: Page/Page column 50; 67
[96] Organic Letters, 2010, vol. 12, # 18, p. 3990 - 3993
[97] Patent: WO2010/120854, 2010, A1, . Location in patent: Page/Page column 136
[98] Organic Letters, 2008, vol. 10, # 5, p. 885 - 887
[99] Langmuir, 2010, vol. 26, # 10, p. 7181 - 7187
[100] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 18, p. 5426 - 5430
[101] European Journal of Organic Chemistry, 2011, # 17, p. 3117 - 3121
[102] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 20, p. 6116 - 6121
[103] Angewandte Chemie - International Edition, 2011, vol. 50, # 41, p. 9708 - 9711
[104] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 23, p. 7089 - 7093
[105] Science China Chemistry, 2011, vol. 54, # 2, p. 375 - 379
[106] Angewandte Chemie - International Edition, 2012, vol. 51, # 1, p. 204 - 208
[107] Journal of the American Chemical Society, 2012, vol. 134, # 16, p. 6976 - 6979
[108] Chemistry - A European Journal, 2012, vol. 18, # 21, p. 6655 - 6662
[109] Russian Journal of Bioorganic Chemistry, 2012, vol. 38, # 2, p. 224 - 229
  • 5
  • [ 79-37-8 ]
  • [ 501-52-0 ]
  • [ 645-45-4 ]
Reference: [1] Journal of the American Chemical Society, 1920, vol. 42, p. 607
[2] Patent: US5618792, 1997, A,
[3] Patent: EP425134, 1991, A1,
  • 6
  • [ 4885-02-3 ]
  • [ 501-52-0 ]
  • [ 107-31-3 ]
  • [ 645-45-4 ]
Reference: [1] Chemische Berichte, 1959, vol. 92, p. 83,86,89
  • 7
  • [ 1257267-04-1 ]
  • [ 3426-71-9 ]
  • [ 501-52-0 ]
Reference: [1] Biochemistry, 2010, vol. 49, # 49, p. 10496 - 10506
  • 8
  • [ 122-97-4 ]
  • [ 104-53-0 ]
  • [ 1124-14-7 ]
  • [ 60045-27-4 ]
  • [ 83-33-0 ]
  • [ 501-52-0 ]
YieldReaction ConditionsOperation in experiment
43 %Chromat. With sodium bromate; sulfuric acid; sodium bromide In water at 20℃; for 24 h; General procedure: A total of 1.0 g of 1-octanol (7.69 mmol) was taken in a 50-mL round-bottomed flask, to it NaBr 0.523 g (0.66 eq.), NaBrO 3 0.383 g (0.33 eq.), and 10 mL of H 2 O [comprises the bromide and bromate in 2:1 molar ratio] were added[6f]. The reaction mixture was stirred vigorously to dissolve the contents completely. To the above reaction mixture, the aqueous H 2 SO 4 solution (0.5 eq.) was added slowly under stirring over a period of 2.5 h at room temperature (prepared by adding 0.21 mL of 98percent H 2 SO 4 to 1 mL of water). The reaction mixture was allowed to stir for up to 24 h. After the completion of reaction, the product was extracted with CH 2 Cl 2 (3 15 mL), the organic layer was dried with Na 2 SO 4 and removal of the solvent obtained octyloctanoate in 98percent yield (0.953 g) as colorless liquid. The product was confirmed by GC–MS as well as by NMR.
Reference: [1] Synthetic Communications, 2018, vol. 48, # 13, p. 1663 - 1670
  • 9
  • [ 501-52-0 ]
  • [ 1643-28-3 ]
  • [ 2019-34-3 ]
Reference: [1] Organic and Biomolecular Chemistry, 2006, vol. 4, # 14, p. 2716 - 2723
[2] Organic and Biomolecular Chemistry, 2006, vol. 4, # 14, p. 2716 - 2723
  • 10
  • [ 3752-25-8 ]
  • [ 1643-28-3 ]
  • [ 501-52-0 ]
Reference: [1] Chemische Berichte, 1918, vol. 51, p. 582
  • 11
  • [ 58-22-0 ]
  • [ 501-52-0 ]
  • [ 1255-49-8 ]
Reference: [1] Patent: DE957030, 1953, ,
  • 12
  • [ 107-92-6 ]
  • [ 501-52-0 ]
  • [ 29898-25-7 ]
Reference: [1] Journal of the Chemical Society, 1925, vol. 127, p. 1097
[2] Annales de Chimie (Cachan, France), 1913, vol. <8> 28, p. 313
[3] Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1911, vol. 152, p. 385[4] Bulletin de la Societe Chimique de France, 1911, vol. <4> 9, p. 952
  • 13
  • [ 501-52-0 ]
  • [ 29898-25-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 13, p. 3257 - 3262
  • 14
  • [ 501-52-0 ]
  • [ 31984-10-8 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1980, vol. 17, # 5, p. 1081 - 1085
[2] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 7, p. 2074 - 2083
  • 15
  • [ 501-52-0 ]
  • [ 35418-07-6 ]
Reference: [1] Journal of Labelled Compounds and Radiopharmaceuticals, 2001, vol. 44, p. S951 - S953
[2] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 8, p. 2445 - 2450
  • 16
  • [ 501-52-0 ]
  • [ 96606-95-0 ]
  • [ 1643-29-4 ]
Reference: [1] Journal of Medicinal Chemistry, 2008, vol. 51, # 22, p. 7061 - 7064
  • 17
  • [ 501-52-0 ]
  • [ 1643-29-4 ]
YieldReaction ConditionsOperation in experiment
75% With potassium iodate; sulfuric acid; iodine; acetic acid In water for 3 h; Reflux lntermediate-1; 3-(4-lodophenyl)propanoic acid.; A mixture of H2SO4 (1.25 ml_), water (12.5 ml.) and AcOH (25 ml.) in a 250 ml. flask and 3-phenylpropanoic acid (3.00 g, 20.0 mmol), iodine (1.40 g, 5.5 mmol) and KIO3 (0.98 g, 4.6 mmol) was added. The reaction was heated to reflux and a solution of iodine (1.40 g, 5.5 mmol) in AcOH (25 ml.) was added in portions of 5 ml. as the colour of the reaction faded from purple to orange. After 3 hours when no further colour changes appeared the reaction was cooled to room temperature, before quenching with 1 M NaHSO3. The reaction was added water and extracted with EtOAc. The organic phases were combined, washed with brine, dried over MgSO4 and concentrated under vacuum. The product (4.15 g, 75percent), containing minor impurites of starting material and the orffro-iodinated product, was recrystallised from PE to provide 1.83 g (33percent) of the pure and white crystalline product. Rf: 0.10 (EtOAσhexanes, 1 :4); 1HNMR (CDCI3) δ 7.62-7.59 (m, 2H), 6.97-6.95 (m, 2H), 2.92-2.87 (t, 2H, J = 7.5 Hz), 2.68-2.63 (t, 2H, J = 7.5 Hz); 13CNMR (CDCI3) δ 178.5, 139.7, 137.6, 130.4, 91.6, 35.2, 30.0.
56% With sulfuric acid; iodine; acetic acid; periodic acid In water at 67℃; for 17 h; A mixture of 3-phenylpropanoic acid (6.00 g, 40.0 mmol), H5IO6 (2.00 g, 8.60 mmol), iodine (4.06 g, 16.0 mmol) and 98percent H2SO4 (1.2 mL) in water (8 mL) and acetic acid (40 mL) was heated at 67 °C for 17 h. The reaction mixture was cooled and quenched with water (100 mL). The crude product was then filtered, washed with water and hexane. The pure product (6.2 g, 56percent) was obtained by recrystallization from toluene. White solid.1H NMR (400 MHz, CDCl3) δ 7.62 (d, J =8.4 Hz, 2 H), 6.97 (d, J = 8.0 Hz, 2 H), 2.91 (t, J = 7.6 Hz, 2 H), 2.67 (t, J = 7.6 Hz, 2 H).
56% With sulfuric acid; iodine; acetic acid; periodic acid In water at 67℃; for 17 h; A mixture of 3-phenylpropanoic acid (6.00 g, 40.0 mmol), H5IO6 (2.00 g, 8.60 mmol), iodine (4.06 g, 16.0 mmol) and 98percent H2SO4 (1.2 mL) in water (8 mL) and acetic acid (40 mL) was heated at 67° C. for 17 h.
The reaction mixture was cooled and quenched with water (100 mL).
The crude product was then filtered, washed with water and hexane.
The pure product (6.2 g, 56percent) was obtained by recrystallization from toluene.
White solid. 1H NMR (400 MHz, CDCl3) δ 7.62 (d, J=8.4 Hz, 2H), 6.97 (d, J=8.0 Hz, 2H), 2.91 (t, J=7.6 Hz, 2H), 2.67 (t, J=7.6 Hz, 2H).
Reference: [1] Patent: WO2010/12650, 2010, A1, . Location in patent: Page/Page column 38
[2] Chemistry - A European Journal, 2009, vol. 15, # 10, p. 2278 - 2288
[3] Journal of the American Chemical Society, 2009, vol. 131, # 47, p. 17500 - 17521
[4] European Journal of Organic Chemistry, 2015, vol. 2015, # 27, p. 5919 - 5924
[5] Patent: WO2016/201125, 2016, A1, . Location in patent: Page/Page column 19
[6] Patent: US2018/66298, 2018, A1, . Location in patent: Paragraph 0162; 0163; 0164
[7] Tetrahedron Asymmetry, 2001, vol. 12, # 4, p. 585 - 596
[8] Journal of the American Chemical Society, 1943, vol. 65, p. 1273,1274
[9] Journal of the Chemical Society, 1930, p. 968,979
[10] Organic Letters, 2008, vol. 10, # 12, p. 2597 - 2600
[11] Patent: WO2004/63169, 2004, A1, . Location in patent: Page 52-53
[12] Patent: US2004/229889, 2004, A1, . Location in patent: Page 20
[13] Patent: US2006/111582, 2006, A1, . Location in patent: Page/Page column 16; 3/4
  • 18
  • [ 501-52-0 ]
  • [ 96606-95-0 ]
  • [ 1643-29-4 ]
Reference: [1] Journal of Medicinal Chemistry, 2008, vol. 51, # 22, p. 7061 - 7064
  • 19
  • [ 91-66-7 ]
  • [ 501-52-0 ]
  • [ 2021-28-5 ]
  • [ 135-91-1 ]
  • [ 102100-44-7 ]
Reference: [1] Chemische Berichte, 1930, vol. 63, p. 489,492
  • 20
  • [ 501-52-0 ]
  • [ 16642-79-8 ]
  • [ 1664-57-9 ]
  • [ 2001-32-3 ]
Reference: [1] Journal of Organic Chemistry, 1998, vol. 63, # 4, p. 952 - 958
  • 21
  • [ 63-91-2 ]
  • [ 7423-92-9 ]
  • [ 587-33-7 ]
  • [ 60-18-4 ]
  • [ 501-52-0 ]
Reference: [1] Applied Catalysis A: General, 2010, vol. 380, # 1-2, p. 142 - 148
[2] Applied Catalysis A: General, 2010, vol. 380, # 1-2, p. 142 - 148
  • 22
  • [ 501-52-0 ]
  • [ 16642-79-8 ]
  • [ 2001-32-3 ]
Reference: [1] Chemische Berichte, 1879, vol. 12, p. 600
[2] Zeitschrift fuer Chemie, 1869, p. 193
[3] Justus Liebigs Annalen der Chemie, 1872, vol. 163, p. 126
[4] Phosphorus, Sulfur and Silicon and the Related Elements, 2004, vol. 179, # 2, p. 221 - 226
[5] Tetrahedron Letters, 2005, vol. 46, # 48, p. 8307 - 8310
  • 23
  • [ 501-52-0 ]
  • [ 16642-79-8 ]
  • [ 1664-57-9 ]
  • [ 2001-32-3 ]
Reference: [1] Journal of Organic Chemistry, 1998, vol. 63, # 4, p. 952 - 958
  • 24
  • [ 7697-37-2 ]
  • [ 501-52-0 ]
  • [ 16642-79-8 ]
  • [ 2001-32-3 ]
Reference: [1] Chemische Berichte, 1879, vol. 12, p. 600
[2] Zeitschrift fuer Chemie, 1869, p. 193
[3] Justus Liebigs Annalen der Chemie, 1872, vol. 163, p. 126
  • 25
  • [ 501-52-0 ]
  • [ 141403-49-8 ]
Reference: [1] Tetrahedron Asymmetry, 2015, vol. 26, # 1, p. 67 - 72
  • 26
  • [ 501-52-0 ]
  • [ 156053-89-3 ]
Reference: [1] Patent: US2017/247328, 2017, A1,
  • 27
  • [ 106-40-1 ]
  • [ 501-52-0 ]
  • [ 316146-27-7 ]
Reference: [1] Chemical Science, 2016, vol. 7, # 2, p. 1276 - 1280
[2] Journal of Chemical Research - Part S, 2003, # 1, p. 10 - 11
[3] Patent: WO2010/36316, 2010, A1, . Location in patent: Page/Page column 47-48
[4] Patent: EP2371819, 2011, A1, . Location in patent: Page/Page column 6
[5] Journal of Medicinal Chemistry, 2013, vol. 56, # 9, p. 3568 - 3581
  • 28
  • [ 501-52-0 ]
  • [ 654655-68-2 ]
Reference: [1] Patent: EP2371819, 2011, A1,
Same Skeleton Products
Historical Records